![Steven Chartier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Chartier
Chief Executive Officer at
BioVentrix, Inc.
Net worth: 1 $ as of 31/01/2026
Profile
Steven J.
Chartier is Co-President, Co-CEO, and Director at BioVentrix, Inc. since 2025.
Mr. Chartier is a Member of the Regulatory Affairs Professionals Society.
Former roles include Chief Operating Officer at BioVentrix, Inc. from 2021 to 2023; Vice President-Regulatory & Clinical Affairs at Anika Therapeutics, Inc. from 2017 to 2018; Chief Operating Officer at PixarBio Corp.
from 2016 to 2017; Director-Regulatory Affairs at NUCRYST Pharmaceuticals Corp.
from 2009 to 2013; Vice President-Operations & Regulatory Affairs at Infraredx, Inc. in 2013; Manager-Clinical Projects at Biogen, Inc.; VP-Regulatory Affairs & Regulatory Affairs at Augmenix, Inc.; Principal at Dana-Farber Cancer Institute, Inc.; and Coordinator-Clinical Trials at Beth Israel Deaconess Medical Center, Inc. Education includes undergraduate studies at St. Anselm College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BioVentrix, Inc.
 BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures 1.93% | 12/02/2026 | 110,530 ( 1.93% ) | 1 $ | 31/01/2026 |
Steven Chartier active positions
| Companies | Position | Start |
|---|---|---|
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Corporate Officer/Principal | - |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Chief Executive Officer | 15/01/2025 |
Former positions of Steven Chartier
| Companies | Position | End |
|---|---|---|
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Chief Operating Officer | 01/12/2023 |
| ANIKA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2018 |
| PIXARBIO CORPORATION | Chief Operating Officer | 02/02/2017 |
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | General Counsel | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | - |
Training of Steven Chartier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Health Technology |
Infraredx, Inc.
 Infraredx, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular imaging devices | Health Technology |
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes medical products that fight infection and inflammation | Health Technology |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
St. Anselm College
 St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
PixarBio Corp.
 PixarBio Corp. Other Consumer ServicesConsumer Services Develops pre-clinical and commercial novel neurological drug delivery systems | Consumer Services |
- Stock Market
- Insiders
- Steven Chartier
